The Outsourcing of R&D through Acquisitions in the Pharmaceutical Industry

Preprint
Publisher Website
Google Scholar
  • 1 January 2003
    • preprint
      • Published in RePEc
Abstract
For acquisitions characterized by information asymmetries, we find evidence consistent with the proposition that acquirers are able to avoid the winner's curse. We examine the performance of acquirers of 160 biotechnology firms from 1994-2001 and find evidence that on average, the acquirers of biotech firms realize significant positive returns. These returns are positively correlated with acquirer access to information about the research and development activities at target firms and a superior negotiating position on the part of the acquirer. Further, we find that acquirers that use equity as payment realize significant positive returns.
All Related Versions

This publication has 0 references indexed in Scilit: